Could stem cells slow Huntington's? new trial tests cellavita HD
Disease control
Completed
This phase 2 trial tested a stem cell therapy called Cellavita HD in 49 people with Huntington's disease. Participants received either a low dose, high dose, or placebo through IV infusions over several months. The study measured changes in motor skills to see if the treatment co…
Phase: PHASE2 • Sponsor: Azidus Brasil • Aim: Disease control
Last updated Jun 26, 2026 18:55 UTC